Session Details
[27-52-am]Science for Drug Formulation 2, Controlled release/DDS
Fri. Mar 27, 2026 9:30 AM - 11:30 AM JST
Fri. Mar 27, 2026 12:30 AM - 2:30 AM UTC
Fri. Mar 27, 2026 12:30 AM - 2:30 AM UTC
Room 52 (B305, Bldg. 1, Area 2 [3F])
Discusser: Shigeru Kawakami, Yuri Ikeuchi
[27-52-am-01]A completely soluble glucose-responsive insulin delivery system employing a self-immolative insulin prodrug and glucose oxidase
○satoshi kitaoka1, Ryo Watanabe1, Minori Kojima1, Miho Koita1, Hiroki Koyama1, Chisato Mori1, Mako Okabe1, Ryusei Ando1, Kaede Kobayashi1, Yuki Takano1, Yuya Egawa1 (1. Faculty of Pharmacy and Pharmaceutical Sciences, Josai University)
[27-52-am-02]Investigation of the effects of conjugation conditions on antibody-modified mRNA-LNP quality and of a scale-up approach
○Masahiro Hashimoto1, Masato Amano1, Shoko Yamazaki1 (1. AGC Inc.)
[27-52-am-03]Development of Folate-Appended Polyrotaxanes for Stabilization and Tumor-Targeting of siRNA Polyplexes
○Koki Hashikawa1, Ahmed Fouad Abdelwahab Mohammed1, Mahmoud H Othman1, Toru Taharabaru1, Keiichi Motoyama1, Taishi Higashi1 (1. Grad. Sch. Pharm. Sci., Kumamoto Univ.)
[27-52-am-04S]Design of Liver-Targeted Cyclodextrin Polymers as Therapeutic Agents for Metabolic Dysfunction-Associated Steatohepatitis
○Rin Onaga1, Toru Taharabaru1, Taishi Higashi1, Keiichi Motoyama1 (1. Graduate School of Pharmaceutical Sciences, Kumamoto University)
[27-52-am-05S]Second-generation Transformable Supramolecular Carriers for siRNA Delivery
○Yuna Miyamae1, Toru Taharabaru1, Keiichi Motoyama1, Taishi Higashi1 (1. Grad.Sch.Pharm.Sci.,Kumamoto Uni.)
[27-52-am-06S]Development of a surface-hydrating modification to improve the blood circulation of tumor microenvironment-responsive liposomes
○Maya Takamura1, Kosho Makino1,2, Nagisa Muto1, Reno Kinoshita1, Ken-Ichiro Tanaka1,2, Shunsuke Sueki1,2, Masahiro Anada1,2, Susumu Hama1,2 (1. Fac. Pharm., Musashino Univ., 2. Res. Inst. Pharm. Sci., Musashino Univ.)
[27-52-am-07S]Regulation of papain enzyme activity via S-nitrosylation for overcoming the cancer-stroma barrier
○Genri Tampo1, Mayumi Ikeda1, Tatsuya Fukuta1, Kazunori Kadota1 (1. Sch. Pharm. Sci., Wakayama Med. Univ.)
[27-52-am-08S]Development of intraperitoneally retentive anticancer nanoparticles for peritoneal dissemination therapy
○Sae Shibatani1, Sumika Igarashi1, Masashi Muroi1,2, Susumu Hama1,2 (1. Fac. Pharm., Musashino Univ., 2. Res. Inst. Pharm. Sci., Musashino Univ.)
[27-52-am-09S]Development of a Liver-Selective Anticancer Drug Delivery Carrier by using Hepatitis B Virus Like Particles
○Momoko Tomoda1, Mari Horita1, Keiji Ueda, Masahiro Fujimuro1 (1. Kyoto Pharmaceutical University)
[27-52-am-10S]Evaluation of penetration and mRNA delivery efficiency of lipid nanoparticles and polymeric micelle-type nanoparticles in tumor spheroids
○Mirai Mitsui1, Natsumi Asakura1, Hiroto Hatakeyama2, Takanori Kanazawa1,3,4 (1. Sch. Pharm. Sci., Tokushima Univ, 2. Grad. Sch. Pharm. Sci., Chiba Univ, 3. Grad. Sch. Biomed. Sci., Tokushima Univ, 4. Inno. Res. Cent. DDS., Tokushima Univ.)